πŸ‡ΊπŸ‡Έ FDA
Patent

US 9090535

Hydroxylated tricyclic compounds

granted A61PA61P25/00A61P25/08

Quick answer

US patent 9090535 (Hydroxylated tricyclic compounds) held by Nektar Therapeutics expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P25/00, A61P25/08, A61P25/24